Navigation Links
Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
Date:2/2/2009

ZURICH, February 2 /PRNewswire/ -- Axentis Pharma AG is to present its recent successes in developing and financing a new therapeutic formulation for treating chronic lung disease at the 2nd Annual European Life Science CEO Forum in Zurich, Switzerland. This invited talk comes just three weeks after the company was asked to present its recent achievements at the Biotech Showcase 2009 in San Francisco, USA. Part of the company's ongoing success story is a recent capital increase that was exceptionally well subscribed by existing private investors.

SIX Swiss Exchange AG is Europe's leading stock exchange for life science companies. Its sponsorship of the European Life Science CEO Forum for Partnering & Investing helps make this one of Europe's most exclusive and highly transactional partnering events.

At this year's forum (February 3 - 4) Dr. Susanne Acklin, COO of Axentis Pharma AG, will be presenting the company's recent successes in developing and financing a new therapeutic formulation for treating chronic lung disease. "2008 was extremely successful for Axentis", explains Acklin. "Our lead product ARB-CF0223 - a liposomal formulation of tobramycin, delivered directly to the site of infection via standard nebulisers - produced very satisfying data from a phase I clinical trial; we initiated a clinical phase II trial and a subsequent capital increase was well received - and subscribed - by our existing private investors. We are very happy with the current position of Axentis and consider it the right time to present the company to experienced institutional investors. That's why we are participating here in Zurich."

Dr. Acklin also serves as Vice President Life Sciences at Venture Valuation AG, a leading independent Swiss company specializing in assessing, valuing and monitoring start-up companies. In this position Acklin has valued well over 100 life science companies and recently deci
'/>"/>

SOURCE Axentis Pharma AG
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
2. Alfacells ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells
3. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
4. ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
5. Pharos Innovations Joins Partnership to Fight Chronic Disease
6. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008
7. UKs NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain
8. New Company to Develop Nutritional Interventions Against Chronic Inflammatory and Infectious Diseases
9. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
10. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
11. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Y and BLENHEIM, Ontario, Nov. 24 /PRNewswire-First...t is acquiring the assets of Hyland Seeds, a divis... addition of Hyland Seeds will further expand Dow ...y anticipates the introduction of SmartStax(TM) ...t Trait Technology in corn in 2012. The transactio...
(Date:11/24/2009)... LOUIS, Nov. 24 Sigma-Al...ing at the NASDAQ OMX conference on Tuesday, Decem...Interested parties may listen via live audio broad... s tor.sig m a a ldrich.com/ . Users can cl..., About Sigma-Aldrich: Sigma-Aldrich is a lead...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PRNews...DCGN ) today announced the approval of all of its,...or the District of Delaware,(the "Bankruptcy Court...r,relief under Chapter 11 of the United States Ban... The orders issued by the Bankruptcy Court allow t...
(Date:11/24/2009)...N MATEO, Calif., Nov. 24 ...ical company focused on developing and commerciali...day that Anthony DiTonno, President and Chief Exec... Annual Piper Jaffray Health Care Conference, to b...otel in New York, New York. ,, Mr. DiTonno and...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...h.D., Research and Development Department,Genet...fred,Nobel Drive, Hercules, CA 94547, , ...ost important factors which must be,optimized in...,microparticle size. Changing most other paramete...fect on transformation efficiencies.,In this rep...
...r, Nina Tang, Lawrence C. Katz, and Donald C. , ... Box 3209, Duke University Medical Center, , ... Introduction , The introduction of ...t , remains a rate-limiting step for mole...pecially neurobiology. Many different methods have...
...ja Kapp, Werner Kunz, and Christoph G Grevelding,... Medical Research,Heinrich-Heine-University, D-... Introduction , Schistosomes are paras...is) , in humans, a tropical disease of wo... One focus of international research on such pa...
Other Biology Technology:Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 2Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 3Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 4Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 5Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 6Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 7Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 8Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 9Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 10Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 11Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 12Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 13Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 14Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 15Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 16Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 17Biolistic Transfection of Organotypic Brain Slices 2Biolistic Transfection of Organotypic Brain Slices 3Biolistic Transfection of Organotypic Brain Slices 4Biolistic Transfection of Organotypic Brain Slices 5Biolistic Transfection of Organotypic Brain Slices 6Biolistic Transfection of Organotypic Brain Slices 7Biolistic Transfection of Organotypic Brain Slices 8Biolistic Transfection of Organotypic Brain Slices 9Biolistic Transfection of Organotypic Brain Slices 10Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 2Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 3Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 4Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 5Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 7Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 8Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 9
(Date:11/24/2009)...t science is opening new doors to understanding ho...he hearing of a marine mammal or if they hear it ...d X-ray scanners that NASA uses to detect flaws in...s now allowing scientists to peek inside the giant... three-dimensional replicas of a whale,s hearing a...
(Date:11/24/2009)...ger and the American College of Medical Toxicology... the publication of the Journal of Medical Toxico...inning in March 2010. It was previously published... Journal of Medical Toxicology , an international... the science and practice of medical toxicology. ...
(Date:11/24/2009)...idge, Md. (November 24, 2009) New research on bac...er ecosystems reveals predictable temporal pattern...unities as markers for monitoring climate change i...k in the Proceedings of the National Academy of S...nities in the six rivers shifted synchronously ove...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Study offers less complex minimally invasive procedure to treat heart valve leak 58466 1Study offers less complex minimally invasive procedure to treat heart valve leak 58466 2LSUHSC researcher identifies new target to prevent fatal flu lung complication 58463 1LSUHSC researcher identifies new target to prevent fatal flu lung complication 58463 2BioMed Central partners with AuthorMapper 10158 1
...belief regarding the cultural spread of tool use a...ees in the Ebo forest, Cameroon, use stone hammers...rient-rich seeds. The findings are significant bec...wn only in a distant chimpanzee population in extr...d by geographical boundaries that prevented cultur...
...they pollinate, has declined significantly in Brit...ording to research led by the University of Leeds ...). The paper is the first evidence of a widespread...aised for years about the loss of pollination serv...been restricted to a few key species or a few foca...
...Standards and Technology (NIST) have demonstrated ... small numbers of biomolecules. The unusually simp...s on single molecule dynamics and perhaps lead to ...ight be used for medical screening or biotechnolog...sue of Applied Physics Letters. , The NIST team cr...
Other Biology News:Use of stone hammers sheds light on geographic patterns of chimpanzee tool use 2Wild bees and the flowers they pollinate are disappearing together 2Wild bees and the flowers they pollinate are disappearing together 3'Micro-boxes' of water used to study single molecules 2
UCB CD4 T Cell Chip-IHC from 3H Biomedical AB
NK Cell Chip-IHC from 3H Biomedical AB
Yeast tRNA 50 l from BD Biosciences Pharmingen
UCB Neutrophil Chip-IHC from 3H Biomedical AB
Biology Products: